Case details for Alexandra Gerda KIHLBERG

Name: Alexandra Gerda KIHLBERG

Name: Consult Pharma Ltd

Date of Birth: 10 / 12 / 1985

Date Order Starts: 19 / 4 / 2022

Disqualification Length: 9 Years 0 Month(s)

CRO Number: 11664831

Last Known Address: 1 Holst Road,, , , , LONDON,, W3 0BJ

Conduct: On 19th May 2020 Alexandra Gerda Kihlberg ( “Mr Kihlberg”) caused Consult Pharma Limited (“Consult”) to obtain a Government-backed Bounce Back Loan (“BBL”) of £50,000 by submitting false or knowingly inaccurate information and disbursed the moneys in a manner that was not for the economic benefit of Consult, contrary to the terms of the BBL scheme. In that: • The Company’s turnover for the year ended 30 November 2019, as stated in the Company’s accounts, was £51,421. He has confirmed that turnover figure is accurate. • In the year ended 30 November 2020 the Company received a total of £75,838.35. He has confirmed that that represented the entirety of the Company’s turnover for that period. • A company was only entitled to a BBL of up to 25% of its turnover under the BBL scheme so the company’s turnover must have been stated as at least £200,000. The Company’s turnover was insufficient to be eligible to receive a BBL in the sum of £50,000. • On 19 May 2020 £50,000 was received in the Company’s bank account, being the proceeds of the BBL. • On 26 May 2020 the sum of £5,000 was paid to a mortgage account with Halifax mortgages. The Company did not own any property; it is understood that the mortgage related to his own property. • On 19 June 2020 the sum of £45,000 was paid directly to him via bank transfer. • He stated that the BBL was used for advertising & salary due to lack of income due to pandemic. • The entirety of the BBL was paid directly to him, or for his benefit. No evidence has been provided to demonstrate that any of the BBL was used for business expenditure. 

This information is correct as at 30 / 3 / 2022

If you believe this page contains any errors, please email with details of the error that you have found.